Prothena Corp Public (PRTA) Retained Earnings (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Retained Earnings of $1.6 billion for Q1 2026, up 235.48% year-over-year from $484.6 million in Q1 2025, and little changed quarter-over-quarter from $1.6 billion in Q4 2025.
Prothena Corp Public (PRTA) Retained Earnings (2012 - 2026) Analysis & Trends
Prothena Corp Public's Retained Earnings history runs 15 years deep, the most recent figure standing at $1.6 billion for Q1 2026.
- In Q1 2026, Retained Earnings rose 235.48% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 235.48% YoY), while the FY2025 annual figure was $1.6 billion, up 2.37% from the prior year.
- Retained Earnings for Q1 2026 stood at $1.6 billion, roughly flat from $1.6 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.6 billion in Q4 2025, with the low at -$1.3 billion in Q3 2025.
- The 5-year median for Retained Earnings is -$752.3 million (2022), against an average of $186.6 million.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings surged 282.1% in 2022, then sank 183.95% in 2025.
- Prothena Corp Public's Retained Earnings stood at $1.5 billion in 2022, then tumbled by 167.38% to -$980.0 million in 2023, then jumped by 262.11% to $1.6 billion in 2024, then increased by 2.37% to $1.6 billion in 2025, then declined by 0.04% to $1.6 billion in 2026.
- Business Quant data shows PRTA's Retained Earnings at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and -$1.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 1.63 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | -1.32 Bn |
| Jun 30, 2025 | -1.29 Bn |
| Mar 31, 2025 | -1.20 Bn |
| Dec 31, 2024 | 1.59 Bn |
| Sep 30, 2024 | 1.58 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | -980.03 Mn |
| Sep 30, 2023 | -912.56 Mn |
| Jun 30, 2023 | -934.50 Mn |
| Mar 31, 2023 | -879.90 Mn |
| Dec 31, 2022 | 1.45 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | -793.60 Mn |
| Mar 31, 2022 | -752.34 Mn |
| Dec 31, 2021 | 1.18 Bn |
| Sep 30, 2021 | -682.88 Mn |